Login

Sander Geophysics receives the 202 Employer Award.|Luise Sander is co-presidents of Sander Geophysics 00:10:00

Share On Facebook Share On Twitter

Luise Sander is co-presidents of Sander Geophysics

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Financial Analysis of ContourGlobal: A Deep Dive into Their Profit Margins and Earnings
00:10:00
FBN, a unit of FOX News Media with bureaus in Chicago, discusses Rumble's view that Twitter caused 'the worst, most egregious' implications.
00:10:00
Empowering Women in Leadership: ACG New York's Ongoing Mission
00:10:00
Argenica Therapeutics' Phase 2 Trials and Growing Share Price: A Conversation with CEO Dr. Liz Dallimore | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
US Banks vs. European Banks: Strength of Ties with China | Hao Hong, chief China strategist , Bank of Communications.
00:10:00
Vijay Chandok of ICICI Securities discusses the sustained growth in derivatives income and initiatives to expand the business on ET NOW.
00:10:00
Maximizing Business Deductions in 2018: Tax Strategies with Qualitax | Sarah Mitchell - Head of Business Taxation, Qualitax
00:10:00
PIMCO CIO Dan Iverson's Take on the Current Market Environment and Bond Investing | Dan Iverson, CIO, PIMCO.
00:10:00
Tilaknagar Industries' Financial Turnaround: Chairman Amit Dhanuka on Overcoming Stress and Achieving Profitability|Amit Dahanukar,Chairman and Managing Director,Tilaknagar Industries Ltd.
00:10:00
Savannah Resources: Leading European Lithium Project
00:10:00
Exploring Political Philosophy with Mark Blitz: Insights from Harvard and Beyond|Mark Blitz,Professor,Claremont McKenna College
00:10:00
TD Synnex CEO Rich Hume discusses with CRN the critical role of AI and generative AI in the IT distribution industry.|Rich Hume is Chief Executive Officer (CEO) of TD SYNNEX.

© 2017 - Neuhu+